Stay up to date on AcuFocus news by reviewing recent coverage and company press releases.
BAUSCH + LOMB ACQUIRES ACUFOCUS, INC.
January 17, 2023
ACUFOCUS ANNOUNCES FIRST COMMERCIAL PATIENTS TREATED WITH THE IC-8® APTHERA™ INTRAOCULAR LENS, THE FIRST AND ONLY SMALL APERTURE LENS FOR CATARACT SURGERY
January 6, 2023
ACUFOCUS ANNOUNCES FDA APPROVAL FOR THE IC-8® APTHERA™ INTRAOCULAR LENS, THE FIRST AND ONLY SMALL APERTURE LENS FOR CATARACT SURGERY
July 25, 2022
ACUFOCUS RECEIVES APPROVABLE LETTER FROM THE U.S. FDA FOR THE IC-8® SMALL APERTURE INTRAOCULAR LENS
December 7, 2021
ACUFOCUS APPOINTS INDUSTRY LEADER JOHN GARLAND AS GLOBAL VICE PRESIDENT OF SALES
June 2, 2021
ACUFOCUS APPOINTS JASON SAFABASH AS VICE PRESIDENT OF RESEARCH & DEVELOPMENT
June 6, 2021
ACUFOCUS ANNOUNCES SUBMISSION OF ITS U.S. PMA TO THE FDA FOR ITS IC-8 SMALL APERTURE IOL
February 23, 2021
ACUFOCUS ANNOUNCES EXPANDED DIOPTER RANGE FOR THE IC-8 SMALL APERTURE LENS
July 28, 2020
ACUFOCUS COMPLETES STUDY ENROLLMENT FOR U.S. IDE CLINICAL TRIAL OF IC-8 LENS
June 14, 2019
FIRST IC-8 SMALL APERTURE IOL IMPLANTED IN THE UNITED STATES
December 18, 2018
ACUFOCUS RECEIVES IDE APPROVAL FROM THE U.S. FDA TO BEGIN CLINICAL STUDY OF THE IC-8 LENS
November 26, 2018
EUROPEAN POST-MARKET STUDY OF ACUFOCUS IC-8 SMALL APERTURE IOL PUBLISHED IN JOURNAL OF CATARACT & REFRACTIVE SURGERY
August 21, 2017
ACUFOCUS SMALL-APERTURE IOL RECEIVES CE MARK FOR EUROPE
September 11, 2014
This site uses cookies to improve your overall web experience. By using our website, you consent to our use of cookies in accordance with our Privacy Policy.
